Gastroesophageal Cancers | Ask the Investigators: Applying Emerging Clinical Research to the Care of Patients with Gastroesophageal Cancers

published 1 month ago by Dr Neil Love

Featuring perspectives from Drs Joseph Chao and Yelena Y Janjigian on cases from the practice of Dr Daniel Catenacci, including the following topics: Introduction (0:00) A man in his mid-50s with HER2-negative, microsatellite stable (MSS) metastatic gastroesophageal junction (GEJ) adenocarcinoma with a PD-L1 combined positive score (CPS) of 20 (6:11) A man in his mid-50s with MSS localized adenocarcinoma of the esophagus with a PD-L1 CPS of 10 (13:56) A man in his late 60s with relapsed HER2-positive, MSS adenocarcinoma of the esophagus with a PD-L1 CPS of 0 (24:59) A woman in her mid-30s with relapsed HER2-positive metastatic gastric cancer who experiences rapid disease progression while receiving trastuzumab deruxtecan (46:38) A man in his late 60s with newly diagnosed FGFR2b-overexpressing metastatic GEJ adenocarcinoma who receives the investigational agent bemarituzumab in combination with modified FOLFOX6 (51:30) CME information and select publications

more episodes from Research To Practice | Oncology Videos